Doege–Potter syndrome
Doege–Potter syndrome is a rare medical condition characterized by the presence of a non-islet cell tumor hypoglycemia (NICTH) due to a solitary fibrous tumor (SFT). The syndrome was first described by Karl Doege and Roy P. Potter in 1930.
Symptoms[edit | edit source]
The main symptom of Doege–Potter syndrome is hypoglycemia, or low blood sugar. This is caused by the production of insulin-like growth factor 2 (IGF-2) by the tumor. Other symptoms can include weight loss, weakness, and fatigue.
Diagnosis[edit | edit source]
Diagnosis of Doege–Potter syndrome can be challenging due to its rarity. It is typically diagnosed through a combination of clinical findings, laboratory tests, and imaging studies. The diagnosis is confirmed by the presence of a solitary fibrous tumor and hypoglycemia.
Treatment[edit | edit source]
Treatment for Doege–Potter syndrome typically involves surgical removal of the tumor. In some cases, medication may be used to manage symptoms of hypoglycemia.
Prognosis[edit | edit source]
The prognosis for Doege–Potter syndrome varies depending on the size and location of the tumor, as well as the patient's overall health. With treatment, some patients may experience a complete resolution of symptoms.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
- Doege–Potter syndrome at WikiMD
Doege–Potter syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD